Showing results (51-60 of 156) with videos related to

Sort By:
Pageof 16
Heart (British Cardiac Society)|November 21, 2020
Prognostic significance of natriuretic peptide levels in atrial fibrillation without heart failureYasuhiro Hamatani, Moritake Iguchi, Kentaro Ueno, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|January 25, 2020
Association of relative wall thickness of left ventricle with incidence of thromboembolism in patients with non-valvular atrial fibrillation: The Fushimi AF RegistryYuji Tezuka, Moritake Iguchi, Yasuhiro Hamatani, et al.
The American Journal of Cardiology|February 22, 2017
Relation of Stroke and Major Bleeding to Creatinine Clearance in Patients With Atrial Fibrillation (from the Fushimi AF Registry)Mitsuru Abe, Hisashi Ogawa, Mitsuru Ishii, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 22, 2017
Current Status and Outcomes of Direct Oral Anticoagulant Use in Real-World Atrial Fibrillation Patients - Fushimi AF RegistryYugo Yamashita, Ryuji Uozumi, Yasuhiro Hamatani, et al.
Journal of Pharmacological Sciences|June 6, 2018
A study on indices of apixaban anticoagulation: A single-center prospective studyMaki Komiyama, Yusuke Miyazaki, Hiromichi Wada, et al.
Heart and Vessels|May 26, 2018
Clinical characteristics and cardiovascular outcomes in patients with atrial fibrillation receiving rhythm-control therapy: the Fushimi AF RegistryYoshimori An, Masahiro Esato, Mitsuru Ishii, et al.
Heart and Vessels|June 29, 2018
Correction to: Clinical characteristics and cardiovascular outcomes in patients with atrial fibrillation receiving rhythm-control therapy: the Fushimi AF RegistryYoshimori An, Masahiro Esato, Mitsuru Ishii, et al.
The American Journal of Cardiology|June 27, 2024
Association of Regression from Sustained to Paroxysmal Atrial Fibrillation with Clinical Outcomes: The Fushimi AF RegistryMasahiro Esato, Akiko Fujino, Yasuhiro Hamatani, et al.
Heart and Vessels|February 21, 2014
Response of urinary liver-type fatty acid-binding protein to contrast media administration has a potential to predict one-year renal outcome in patients with ischemic heart diseaseDaishi Fujita, Masao Takahashi, Kent Doi, et al.
Internal Medicine (Tokyo, Japan)|October 1, 2020
Late-onset Hereditary ATTR Amyloidosis with a Novel p.P63S (P43S) Transthyretin VariantYuya Aono, Yasuhiro Hamatani, Nagaaki Katoh, et al.
Pageof 16